We are always researching new frontiers in metabolic health and technology. Read below for our latest findings and insights.
ENDRA presents AASLD Symposium with Dr Malik and Dr Kowdley on non invasive diagnostic of NAFLD and the current and future therapies in NASH
Watch the Video >
ENDRA presents AASLD Symposium with Dr Malik and Dr Kowdley on non invasive diagnostic of NAFLD and the current and future therapies in NASH
2020 Presentation by Raza Malik, M.D., Ph.D.
Watch the video >
2020 Presentation by Raza Malik, M.D., Ph.D.
Presentation by Raza Malik, M.D., Ph.D.
A new non-invasive approach to identifying levels of liver fat could deliver an important boost in the fight against liver disease.
Read more >
ENDRA Life Sciences is active in external research collaborations with both academic and private research organizations. The policy of ENDRA Life Sciences is to limit the amount of indirect costs associated with any research funding it provides to any research organizations, to 15% through Sponsored Research Agreements, Collaborative Research Agreements, or other research related agreements.
ENDRA shall not agree to overhead costs, indirect costs or other research associated costs above fifteen percent (15%) of the cost of the contracted research amount.
|
ENDRA is certified to ISO 13485:2016 Learn More> |
ENDRA operates a Quality Management System which complies with the requirements of ISO 13485:2016 & EN ISO 13485:2016 for the following scope:
Certificate number: MD 697226
Effective Date: 2025-04-02
Expiry Date: 2028-04-01
